ACHVACHIEVE LIFE SCIENCES, INC.(ACHV)Stock Analysis

AI analysis on 2,800+ stocks →
HealthcareNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 949858ACHV stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

ACHV Stock Analysis & AI Quality Score

AI stock analysis and institutional research for ACHIEVE LIFE SCIENCES, INC. (ACHV), a Healthcare sector company. ACHV is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Based on the latest XBRL financial filings (Q1 2026), ACHIEVE LIFE SCIENCES, INC. reports net income of $-10.2M, free cash flow of $-6.9M. Top institutional holders of ACHV by reported 13-F value include FRANKLIN RESOURCES, Propel Bio Management,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ACHV trades on the Nasdaq exchange and files with the SEC under CIK 949858. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACHV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ACHIEVE LIFE SCIENCES, INC. directly from SEC EDGAR.

Net Income

Q1 2026

$-10.2M

Free Cash Flow

Q1 2026

$-6.9M

Get alerted when ACHV's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for ACHIEVE LIFE SCIENCES, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of ACHV

Put ACHV on your watchlist

Track score changes the day ACHIEVE LIFE SCIENCES, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is ACHV a good stock to buy?

13F Pro's AI-powered analysis of ACHIEVE LIFE SCIENCES, INC. (ACHV) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACHV are available on the ACHV stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ACHV?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACHV. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ACHIEVE LIFE SCIENCES, INC.'s investment landscape.